小分子调制MHC-I表面表达:一个基于点击化学的发现方法
Sarah E Newkirk1, Joey J Kelly1, Mahendra D Chordia1
1Department of Chemistry, University of Virginia, Charlottesville, Virginia 22904, United States.
Journal of medicinal chemistry
|October 27, 2025
概括
研究人员确定了小分子,这些小分子增加了癌细胞上Major Histocompatibility Complex class I (MHC-I) 的表达. 这种方法,使用点击化学,增强T细胞激活,以打击免疫逃避,并可能改善癌症免疫疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 药用化学 医学化学
背景情况:
- 免疫疗法利用免疫系统对抗癌症.
- 主体组织相容性复合体I类 (MHC-I) 向CD8+T细胞呈现抗原,用于癌细胞的识别.
- 癌细胞通过降低MHC-I表面表达的调节来逃避免疫检测.
研究的目的:
- 为了确定可以治疗性地增加MHC-I表面表达的小分子.
- 发现能够克服癌症免疫逃避机制的新型化合物.
主要方法:
- 评估已知的小分子MHC-I诱导剂.
- 确定了热冲击蛋白90 (HSP90) 抑制剂作为有效的增强剂.
- 利用基于化学的现场点击衍生策略合成380种新型化合物.
主要成果:
- 确定了具有高MHC-I诱导水平的新型小分子.
- 发现一种基于三醇的类似物ClimMB-325,可以增强T细胞激活.
- 与现有方法相比,新型化合物的毒性较低.
结论:
- 基于化学的多样化是发现小分子以增强癌症免疫治疗的可行策略.
- 准MHC-I表达可以克服癌症免疫逃避.
- 克利姆B-325显示作为癌症免疫治疗的治疗剂的承诺.
相关概念视频
01:31Antigen Processing Pathways
2.1K
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
2.1K
01:26Antigens Involved in Adaptive Immunity
1.3K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.3K